Analysis of CYP2C9 polymorphisms (*2 and *3) in warfarin therapy patients in Pakistan. Association of CYP2C9 polymorphisms (*2 and*3) with warfarin dose, age, PT and INR.
about
Analysis of CYP2C9 polymorphisms (*2 and *3) in warfarin therapy patients in Pakistan. Association of CYP2C9 polymorphisms (*2 and*3) with warfarin dose, age, PT and INR.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Analysis of CYP2C9 polymorphis ...... arfarin dose, age, PT and INR.
@en
Analysis of CYP2C9 polymorphis ...... arfarin dose, age, PT and INR.
@nl
type
label
Analysis of CYP2C9 polymorphis ...... arfarin dose, age, PT and INR.
@en
Analysis of CYP2C9 polymorphis ...... arfarin dose, age, PT and INR.
@nl
prefLabel
Analysis of CYP2C9 polymorphis ...... arfarin dose, age, PT and INR.
@en
Analysis of CYP2C9 polymorphis ...... arfarin dose, age, PT and INR.
@nl
P2093
P2860
P1476
Analysis of CYP2C9 polymorphis ...... arfarin dose, age, PT and INR.
@en
P2093
Abdul Wadood Khalid
Faiza Yasmeen
Muhammad Bilal Ghafoor
Shagufta Khaliq
Shahida Mohsin
Waqas Latif
P2860
P2888
P304
P356
10.1007/S11239-015-1215-5
P577
2015-08-01T00:00:00Z